Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L03" (51)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Filgrastim (L03AA02) 13 products
WHO-DDD
DrugBank.ca
L
IP
Neupogen Amgen 30
5 1 Durchstechflasche(n) à 1 ml
299.12
340.75
10 %
Injection solution: Filgrastimum 30 Mio U/ml
Amgen Switzerland AG
A / SL
FB
G
L
IP
Accofil 300mcg/0.5ml
57.43
78.85
10 %
Injection solution in prefilled syringe: Filgrastimum 30Mio. U. / 0.5ml
Accord Healthcare AG
A / SL
FB
G
L
IP
Accofil 300mcg/0.5ml
5
293.98
335.45
10 %
Injection solution in prefilled syringe: Filgrastimum 30Mio. U. / 0.5ml
Accord Healthcare AG
A / SL
FB
G
L
IP
Accofil 480mcg/0.5ml
82.76
106.40
10 %
Injection solution in prefilled syringe: Filgrastimum 48Mio. U. / 0.5ml
Accord Healthcare AG
A / SL
FB
G
L
IP
Accofil 480mcg/0.5ml
5
413.82
465.50
10 %
Injection solution in prefilled syringe: Filgrastimum 48Mio. U. / 0.5ml
Accord Healthcare AG
A / SL
FB
G
L
IP
Filgrastim-Teva 30 / 0.5 ml
syringe(s)
57.43
78.85
10 %
Injection solution in prefilled syringe: Filgrastimum 30Mio. U. / 0.5ml
Teva Pharma AG
● 
A / SL
FB
G
L
IP
Filgrastim-Teva 48 / 0.8 ml
syringe(s)
82.76
106.40
10 %
Injection solution in prefilled syringe: Filgrastimum 48Mio. U. / 0.8ml
Teva Pharma AG
A / SL
FB
G
L
IP
Filgrastim-Teva 30 / 0.5 ml
5 syringe(s)
293.98
335.45
10 %
Injection solution in prefilled syringe: Filgrastimum 30Mio. U. / 0.5ml
Teva Pharma AG
A / SL
FB
G
L
IP
Filgrastim-Teva 48 / 0.8 ml
5 syringe(s)
413.82
465.50
10 %
Injection solution in prefilled syringe: Filgrastimum 48Mio. U. / 0.8ml
Teva Pharma AG
A / SL
FB
G
L
IP
Neupogen Amgen 30
5 1 syringe(s) à 0.5 ml
299.12
340.75
10 %
Injection solution in prefilled syringe: Filgrastimum 30Mio. U. / 0.5ml
Amgen Switzerland AG
A / SL
FB
G
L
IP
Neupogen Amgen 48
5 1 syringe(s) à 0.5 ml
421.05
472.95
10 %
Injection solution in prefilled syringe: Filgrastimum 48Mio. U. / 0.5ml
Amgen Switzerland AG
A / SL
FB
G
L
IP
Zarzio 30 MU/0.5 ml
5 syringe(s)
293.98
335.45
10 %
Injection solution in prefilled syringe: Filgrastimum
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Zarzio 48 MU/0.5 ml
5 syringe(s)
413.81
465.50
10 %
Injection solution in prefilled syringe: Filgrastimum
Sandoz
Pharmaceuticals AG
A / SL
FB
G
Pegfilgrastim (L03AA13) 7 products
WHO-DDD
DrugBank.ca
L
IP
CI
Fulphila 6 mg
1001.72
1105.85
10 %
Injection solution: Pegfilgrastimum 6mg / 0.6ml
Medius AG
A / SL
FB
G
L
SIP
IP
CI
Neulasta
syringe(s)
1101.89
1208.60
10 %
Injection solution in prefilled syringe: Pegfilgrastimum 6mg / 0.6ml
Amgen Switzerland AG
A / SL
FB
G
L
IP
CI
Pelgraz 6 mg/ 0.6 ml
1001.72
1105.85
10 %
Injection solution in prefilled syringe: Pegfilgrastimum 6mg / 0.6ml
Accord Healthcare AG
A / SL
FB
G
L
IP
CI
Ziextenzo 6 mg / 0.6 ml
1001.72
1105.85
10 %
Injection solution in prefilled syringe: Pegfilgrastimum 6mg / 0.6ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
CI
Pelgraz 6 mg/0.6 ml
1001.72
1105.85
10 %
Injektionslösung in Fertiginjektor: Pegfilgrastimum 6mg / 0.6ml
Accord Healthcare AG
A / SL
FB
G
L
IP
CI
Grasustek 6 mg
1001.72
1105.85
10 %
solution injectable en seringue préremplie: Pegfilgrastimum 6mg / 0.6ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
IP
CI
Ziextenzo 6 mg / 0.6 ml
24
26378.16
27283.60
k.A.
Injection solution in prefilled syringe: Pegfilgrastimum 6mg / 0.6ml
Sandoz
Pharmaceuticals AG
A
FB
G
Interferon Gamma (L03AB03) 1 products
WHO-DDD
DrugBank.ca
IP
Imukin
6 Durchstechflasche(n)
1067.66
1232.45
k.A.
Injection solution: Interferonum Humanum Gamma-1b Adnr
Curatis AG
A
FB
G
Interferon Beta-1a (L03AB07) 10 products
WHO-DDD
DrugBank.ca
IP
CI
Avonex
Set(s)
820.96
909.25
10 %
Injection solution in prefilled syringe: Interferonum Beta-1a Adnr 30 µg
Biogen Switzerland AG
B / SL
FB
G
IP
CI
Rebif 22
12 syringe(s)
717.95
797.25
10 %
Injection solution in prefilled syringe: Interferonum Beta-1a Adnr 22 µg
Merck (Schweiz) AG
B / SL
FB
G
IP
CI
Rebif 44
12 syringe(s)
836.58
926.25
10 %
Injection solution in prefilled syringe: Interferonum Beta-1a Adnr 44 µg
Merck (Schweiz) AG
B / SL
FB
G
IP
CI
Rebif 8.8 und 22
6 Kombipackung(en)
599.44
668.35
10 %
Injection solution in prefilled syringe: Interferonum Beta-1a Adnr 8.8µg / 0.2ml
Injection solution in prefilled syringe: Interferonum Beta-1a Adnr 22µg / 0.5ml
Merck (Schweiz) AG
B / SL
FB
G
IP
CI
Rebif 22 RebiDose
12 syringe(s)
717.95
797.25
10 %
Injektionslösung im Fertigpen: Interferonum Beta-1a Adnr 22 µg
Merck (Schweiz) AG
B / SL
FB
G
IP
CI
Rebif 44 RebiDose
12 syringe(s)
836.58
926.25
10 %
Injektionslösung im Fertigpen: Interferonum Beta-1a Adnr 44 µg
Merck (Schweiz) AG
B / SL
FB
G
IP
CI
Rebif 8.8 und 22 RebiDose
6 syringe(s)
599.44
668.35
10 %
Injektionslösung im Fertigpen: Interferonum Beta-1a Adnr 8.8µg / 0.2ml
Injektionslösung im Fertigpen: Interferonum Beta-1a Adnr 22µg / 0.5ml
Merck (Schweiz) AG
B / SL
FB
G
IP
CI
Rebif 22 multidose
4 piece(s)
717.95
797.25
10 %
Injektionslösung in Patronen: Interferonum Beta-1a Adnr 66 µg
Merck (Schweiz) AG
B / SL
FB
G
IP
CI
Rebif 44 multidose
4 piece(s)
836.58
926.25
10 %
Injektionslösung in Patronen: Interferonum Beta-1a Adnr 132 µg
Merck (Schweiz) AG
B / SL
FB
G
IP
CI
Avonex Pen
4 Set(s)
820.96
909.25
10 %
Injektionslösung in einem Fertigpen: Interferonum Beta-1a Adnr 30 µg
Biogen Switzerland AG
B / SL
FB
G
Interferon Beta-1b (L03AB08) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Betaferon
Kombipackung(en)
827.06
915.90
10 %
Lyophilisate and solvent: Interferonum Beta-1b Adnr
Bayer (Schweiz) AG
B / SL
FB
G
Peginterferon Alfa-2a (L03AB11) 2 products
WHO-DDD
DrugBank.ca
L
IP
CI
Pegasys 135 mcg/0,5 ml
4 x 0.5 ml
559.77
625.20
10 %
Injection solution in prefilled syringe: Peginterferonum Alfa-2a 135µg / 0.5ml
CPS Cito Pharma
Services GmbH
A / SL
FB
G
L
IP
CI
Pegasys 180 mcg/0,5 ml
4 x 0.5 ml
639.68
712.10
10 %
Injection solution in prefilled syringe: Peginterferonum Alfa-2a 180µg / 0.5ml
CPS Cito Pharma
Services GmbH
A / SL
FB
G
Peginterferon Beta-1a (L03AB13) 4 products
WHO-DDD
DrugBank.ca
IP
CI
PP
Plegridy Pen, 63 mcg/0.5 ml
Kombipackung(en)
801.41
888.00
10 %
Peginterferonum Beta-1a 63µg / 0.5ml
Biogen Switzerland AG
B / SL
FB
G
IP
CI
PP
Plegridy Pen, 125 mcg/0.5 ml
2 piece(s)
834.66
924.15
10 %
Peginterferonum Beta-1a 125µg / 0.5ml
Biogen Switzerland AG
B / SL
FB
G
IP
CI
Plegridy 125 mcg/0.5 ml
2
834.66
924.15
10 %
Injektionslösung in einer Fertigspritze zur intramuskulären Anwendung: Peginterferonum Beta-1a 125µg / 0.5ml
Biogen Switzerland AG
B / SL
FB
G
IP
CI
PP
Plegridy Pen, 94 mcg/0.5 ml
Kombipackung(en)
k.A.
Peginterferonum Beta-1a 94µg / 0.5ml
Biogen Switzerland AG
B
FB
G
Ropeginterferon Alfa-2b (L03AB15) 2 products
WHO-DDD
L
IP
CI
Besremi 250 μg / 0,5 ml
1505.56
1653.80
10 %
Injektionslösung im Fertigpen: Ropeginterferonum Alfa-2b 250µg / 0.5ml
OrPha Swiss GmbH
A / SL
FB
G
IP
CI
Besremi 500 μg / 0,5 ml
k.A.
Injektionslösung im Fertigpen: Ropeginterferonum Alfa-2b 500µg / 0.5ml
OrPha Swiss GmbH
A
FB
G
Aldesleukin (L03AC01) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Proleukin
Durchstechflasche(n)
k.A.
poudre pour solution à diluer pour perfusion: Aldesleukinum 18 Mio UI
Curatis AG
A
FB
G
Other Immunostimulants (L03AX) 1 products
WHO-DDD
Synerga 750 mg
100 ml
k.A.
Solution (oral): Escherichiae coli Lysatum (Stamm Laves)
Laves-Arzneimittel
Gesellschaft mit
beschränkter Haftung,
Ronnenberg,
Zweigniederlassung
Schötz
D
FB
G
Bcg Vaccine (L03AX03) 1 products
WHO-DDD
DrugBank.ca
IP
OncoTICE
Durchstechflasche(n)
97.53
122.50
10 %
Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung: Bacillus Calmette-Guérin (Bcg) Vivus Attenuatum (Tice) 200-800
MSD Merck Sharp &
Dohme AG
● 
A / SL
FB
G
Tasonermin (L03AX11) 1 products
WHO-DDD
IP
Beromun
4
k.A.
Lyophilisate: Tasonerminum 1 mg
Eumedica
Pharmaceuticals AG
A
FB
G
Glatiramer Acetate (L03AX13) 6 products
WHO-DDD
IP
CI
Copaxone 20mg/ml
28 Fertigspritze(n)
778.94
855.90
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 20 mg/ml
Teva Pharma AG
B / SL / SO
FB
G
L
IP
CI
Copaxone 40mg/ml
12
737.70
805.10
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 40 mg/ml
Teva Pharma AG
B / SL / SO
FB
G
IP
CI
Glatiramyl 20 mg/ml
28
654.31
728.00
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 20 mg/ml
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Glatiramyl 40 mg/ml
12
516.39
578.00
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 40 mg/ml
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
Copaxone Pen 40 mg/ml
12
737.70
805.10
10 %
Injektionslösung im Fertigpen: Glatirameri Acetas 40 mg/ml
Teva Pharma AG
B / SL
FB
G
IP
CI
Copaxone Pen 40 mg/ml
3
k.A.
Injektionslösung im Fertigpen: Glatirameri Acetas 40 mg/ml
Teva Pharma AG
B
FB
G
Plerixafor (L03AX16) 1 products
WHO-DDD
DrugBank.ca
IP
PP
Mozobil 20mg/mL
Durchstechflasche(n)
k.A.
Injection solution: Plerixaforum 20 mg/ml
Sanofi-Aventis
(Suisse) SA
A
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home